Evidence map›Paper›PMID 36677318›Full record

ArticleMicroorganisms2022

Comparative Genomic Analyses of New and Old World Viscerotropic Leishmanine Parasites: Further Insights into the Origins of Visceral Leishmaniasis Agents.

Fernando Tobias Silveira, Edivaldo Costa Sousa Junior, Rodrigo Vellasco Duarte Silvestre, Thiago Vasconcelos Dos Santos, Wilfredo Sosa-Ochoa, Concepción Zúniga Valeriano, Patrícia Karla Santos Ramos, Samir Mansour Moraes Casseb, Luciana Vieira do Rêgo Lima, Marliane Batista Campos and 6 more

Open access · goldAbstract read
In one paragraph

Article in Microorganisms, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Advances inMicroorganisms · 2023
    Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 3 institutions in 2 countries.

Fernando Tobias SilveiraParasitology Department, Evandro Chagas Institute, Ananindeua 67030-000, Pará State, Brazil.ORCID 0000-0002-0412-6060
Edivaldo Costa Sousa JuniorParasitology Department, Evandro Chagas Institute, Ananindeua 67030-000, Pará State, Brazil.
Rodrigo Vellasco Duarte SilvestreVirology Department, Evandro Chagas Institute, Ananindeua 67030-000, Pará State, Brazil.
Thiago Vasconcelos Dos SantosParasitology Department, Evandro Chagas Institute, Ananindeua 67030-000, Pará State, Brazil.ORCID 0000-0002-0229-4861
Wilfredo Sosa-OchoaMicrobiology School, National Autonomous University of Honduras, Tegucigalpa 11101, Honduras.ORCID 0000-0003-1387-7488
Concepción Zúniga ValerianoHealth Surveillance Department, School Hospital, Autonomous University of Honduras, Tegucigalpa 11101, Honduras.
Patrícia Karla Santos RamosParasitology Department, Evandro Chagas Institute, Ananindeua 67030-000, Pará State, Brazil.
Samir Mansour Moraes CassebArbovirology Department, Evandro Chagas Institute, Ananindeua 67030-000, Pará State, Brazil.
Luciana Vieira do Rêgo LimaParasitology Department, Evandro Chagas Institute, Ananindeua 67030-000, Pará State, Brazil.ORCID 0000-0002-3240-2835
Marliane Batista CamposParasitology Department, Evandro Chagas Institute, Ananindeua 67030-000, Pará State, Brazil.
Vania Lucia da MattaPathology Laboratory of Infectious Diseases (LIM50), Pathology Department, Medical School, São Paulo University, São Paulo 1246-903, São Paulo State, Brazil.ORCID 0000-0003-3509-6121
Claudia Maria GomesPathology Laboratory of Infectious Diseases (LIM50), Pathology Department, Medical School, São Paulo University, São Paulo 1246-903, São Paulo State, Brazil.ORCID 0000-0001-9909-9466
Gabriela V Araujo FloresPathology Laboratory of Infectious Diseases (LIM50), Pathology Department, Medical School, São Paulo University, São Paulo 1246-903, São Paulo State, Brazil.
Carmen M Sandoval PachecoPathology Laboratory of Infectious Diseases (LIM50), Pathology Department, Medical School, São Paulo University, São Paulo 1246-903, São Paulo State, Brazil.
Carlos Eduardo CorbettPathology Laboratory of Infectious Diseases (LIM50), Pathology Department, Medical School, São Paulo University, São Paulo 1246-903, São Paulo State, Brazil.
Márcia Dalastra LaurentiPathology Laboratory of Infectious Diseases (LIM50), Pathology Department, Medical School, São Paulo University, São Paulo 1246-903, São Paulo State, Brazil.ORCID 0000-0002-1080-2440
Instituto Evandro Chagas · BRUniversidade de São Paulo · BRNational Autonomous University of Honduras · HN

Funding

São Paulo Research Foundation 2014/50315-0
6 · The paper itself

Abstract

Visceral leishmaniasis (VL), also known as kala-azar, is an anthropozoonotic disease affecting human populations on five continents. Aetiologic agents belong to the Leishmania (L.) donovani complex. Until the 1990s, three leishmanine parasites comprised this complex: L. (L.) donovani Laveran & Mesnil 1903, L. (L.) infantum Nicolle 1908, and L. (L.) chagasi Lainson & Shaw 1987 (=L. chagasi Cunha & Chagas 1937). The VL causal agent in the New World (NW) was previously identified as L. (L.) chagasi. After the development of molecular characterization, however, comparisons between L. (L.) chagasi and L. (L.) infantum showed high similarity, and L. (L.) chagasi was then regarded as synonymous with L. (L.) infantum. It was, therefore, suggested that L. (L.) chagasi was not native to the NW but had been introduced from the Old World by Iberian colonizers. However, in light of ecological evidence from the NW parasite’s enzootic cycle involving a wild phlebotomine vector (Lutzomyia longipalpis) and a wild mammal reservoir (the fox, Cerdocyon thous), we have recently analyzed by molecular clock comparisons of the DNA polymerase alpha subunit gene the whole-genome sequence of L. (L.) infantum chagasi of the most prevalent clinical form, atypical dermal leishmaniasis (ADL), from Honduras (Central America) with that of the same parasite from Brazil (South America), as well as those of L. (L.) donovani (India) and L. (L.) infantum (Europe), which revealed that the Honduran parasite is older ancestry (382,800 ya) than the parasite from Brazil (143,300 ya), L. (L.) donovani (33,776 ya), or L. (L.) infantum (13,000 ya). In the present work, we have now amplified the genomic comparisons among these leishmanine parasites, exploring mainly the variations in the genome for each chromosome, and the number of genomic SNPs for each chromosome. Although the results of this new analysis have confirmed a high genomic similarity (~99%) among these parasites [except L. (L.) donovani], the Honduran parasite revealed a single structural variation on chromosome 17, and the highest frequency of genomic SNPs (more than twice the number seen in the Brazilian one), which together to its extraordinary ancestry (382,800 ya) represent strong evidence that L. (L.) chagasi/L. (L.) infantum chagasi is, in fact, native to the NW, and therefore with valid taxonomic status. Furthermore, the Honduran parasite, the most ancestral viscerotropic leishmanine parasite, showed genomic and clinical taxonomic characteristics compatible with a new Leishmania species causing ADL in Central America.

Indexed as

comparative genomic analysesLeishmania (L.) donovaniLeishmania (L.) infantumLeishmania (L.) infantum chagasiNew and Old Worldvisceral leishmaniasis agents

Identifiers

PMID36677318
PMCPMC9865424
OpenAlexW4313235956

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.